Helius Medical Technologies (HSDT)(HSM:CA) - 3Q21 Results Raises $9.8 million net

Stock Information for Helius Medical Technologies Inc. Class A common shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Helius Medical Technologies Inc. Class A common shares

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
Helius Medical Technologies Announces Reverse Stock Split

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.